Dolphin
Senior Member (Voting Rights)
Hospital Care Plan for Severe-Very Severe ME/CFS and long COVID (and associated conditions, e.g.: dysautonomia)
Unfortunately, this is standard from ANZMES. Fiona Charlton who leads ANZMES was one of the authors of a recent paper that wrecked what could have been good basic information about what we know about number of people affected in New Zealand and services available by adding in a whole lot of unfounded conjecture. She has been told by a number of people that she is not helping ME/CFS advocacy by being so certain about things, but she seems very confident in her knowledge.There is a lot of unnecessary material about speculated pathologies and problems. As it is I think it will put health professionals off quite quickly and they will ignore it.
That about sums it up. They do cite your Qeios piece (thread) multiple times so there's thatI am unclear on a brief skimming who this is intended for. It seems to try to put too much in to one document - with different material potentially being aimed at different people. There is a lot of unnecessary material about speculated pathologies and problems. As it is I think it will put health professionals off quite quickly and they will ignore it. That would be a pity because there are a lot of elements that are relevant to simple practical matters.
Is there any way they may be open to a refined edited down version?Unfortunately, this is standard from ANZMES
Is there any way they may be open to a refined edited down version?
Not to discourage anyone from trying but that won’t be easyIs there any way they may be open to a refined edited down version?
I’m beginning to think we need to put more urgency into expanding and promoting our fact sheet project. It might not help in this specific case but there are bound to be other organisations who would adopt our fact sheets even if only because they’re too resource constrained themselves to create or update their ownEither way, lets do it.
There are several motley publications worth sieving though and filtering.
Thanks @Ravnbig stumbling block is that they genuinely believe all their claims are solidly evidence-based. I don’t know how to convince them otherwise. It doesn’t help that at least some of them are downright allergic to S4ME
Yes, relying upon ill individuals and trying to reach consensus is obviously very energy and time consuming so a limiting factor. I wonder if there’s some way we could find a good professional science writer or communicator to employ to do some of the work and take the load off?I’m beginning to think we need to put more urgency into expanding and promoting our fact sheet project.
Thank you for doing that. It's such a shame that they aren't listening and taking advantage of your expertise and skills. I wish there was a way to convince them. It's hard to believe that they can't see what we see.These last months I’ve spent a huge chunk of my screen-time budget on trying to convince our advocates that they’d be more effective if they restricted their messaging to the most important and best evidenced points, to little avail.
Outside of a narrow stratum of private "POTS specialists" the term "dysautonomia" is considered to refer to conditions such as pure autonomic failure and multiple system atrophy/Shy-Drager syndrome. And regardless of any debates about the conceptual validity of POTS there is no hard evidence of association with definitive autonomic disorder in the classical sense.Hospital Care Plan for Severe-Very Severe ME/CFS and long COVID (and associated conditions, e.g.: dysautonomia)
It needs supportive medical and nursing care and accommodations. "A multidisciplinary approach" will inevitably be interpreted to include psychology, physiotherapy etc. And the term "complex" is best avoided - in some contexts it can have a subtle dual meaning that many patients perhaps don't appreciate.involves a multidisciplinary approach to address the complex and debilitating symptoms
The only evidence that I regard as sufficiently serious to cite in guidance comes from the two main prospective studies (Dubbo & Jason) - they have their own limitations but I think it would be reasonable for the authors of guidance documents to draw a link to glandular fever based on those. Mentioning post-COVID cases would also be reasonable. Everything else exists somewhere between speculation and evidence of such low quality that it should not feature in documents put out by national charities.ME/CFS can also be triggered by bacterial infections, adverse or allergic reactions to surgical anaesthesia, vaccinations, medications, chemical or toxin exposure, hormonal changes in pregnancy, childbirth, or peri(menopause), and environmental stressors such as trauma and abuse.
Does it, though? The most reliable evidence here comes from the DecodeME preprint.ME/CFS affects multiple body systems including: immune, neurological, endocrine, autonomic, gastrointestinal, and cardiovascular.
I think some patients think that "100-200+ symptoms" must inherently be more believable than a small cluster of core symptoms likely to have a single unifying cause. That is.. not the case. This is likely to come across to the average medic in much the same way as the patient who produces a list of their 50 allergies.This results in 100-200+ symptoms, and can be highly individualistic
I have to ask: would this sentence be added to a document about another often invisible illness - MS, say, or SLE? Because we really need to move to a point where ME/CFS is simply discussed as a disease like any other.Those treating and interacting with patients with severe-very severe ME/CFS and long COVID must be aware these patients DO NOT want to be sick.
The Dubbo study found a very similar impact in terms of post-infectious symptoms from EBV, Ross River Fever and Q fever infections. There is quite a bit of evidence that Q fever fatigue syndrome is the same thing. as ME/CFS. Because Q fever is caused by a bacteria, I think it is valid to say that ME/CFS can be caused by some viral infections and some bacterial infections.The only evidence that I regard as sufficiently serious to cite in guidance comes from the two main prospective studies (Dubbo & Jason) - they have their own limitations but I think it would be reasonable for the authors of guidance documents to draw a link to glandular fever based on those. Mentioning post-COVID cases would also be reasonable. Everything else exists somewhere between speculation and evidence of such low quality that it should not feature in documents put out by national charities.
Symptoms can worsen after physical, cognitive and emotional effort, as well as orthostatic, environmental, and sensory stress. When subjected to these stressors, patients may experience a flare of exhaustion, cognitive impairment, pain and sensory amplification, headaches, autonomic dysregulation, dizziness, flu-like symptoms, or even non-epileptic seizures related to diffuse cerebral hypoperfusion.
Common comorbid conditions in ME/CFS that may be responsible for flares or driving presenting symptoms include:
• Mast cell activation syndrome
• Small fiber polyneuropathies
• Postural orthostatic tachycardia syndrome (POTS)
• Gastrointestinal dysautonomia and functional GI dysmotility
• Pain amplification disorders (to include fibromyalgia)
• Multiple chemical or sensory sensitivities
• Primary sleep disorders
• Small intestine bacterial overgrowth (SIBO)
• Cranio-cervical instability
• Hypermobile Ehlers’s Danlos syndrome
• Sicca syndrome
• Celiac disease
• Autoimmune thyroid disease, euthyroid sick syndrome
Use medications thoughtfully and skillfully with close monitoring
• Patients with ME/CFS may be unusually sensitive to medication effects and more likely to have intolerances or allergic reactions. Medication side effects may be related to an exaggerated sympathetic nervous system response to foreign substances and not reflect known pharmacological side effects of medications.
• Start low (10 - 25% of usual) with medication doses. Consider past intolerances and experiences.
• Be cautious about abruptly stopping benzodiazepines and opioids, as the withdrawal can be amplified and dramatically provoke rebound symptoms.
• Consider "stress doses" of hydrocortisone (5-10 mg bid) as though the patient has adrenal insufficiency. Though cortisol levels may be normal, cellular response to normal cortisol levels is often downregulated.
Yes, and many post-acute Lyme disease cases seem to be ME/CFS, too. But hard evidence that goes to causation such as from prospective studies is surprisingly thin on the ground. Also not sure that I'd assume that a lot of post-Ebola syndrome is ME/CFS - given its severity recovery from Ebola may be particularly prolonged & if I recall correctly there is also some evidence of persistence in the post acute phase for a period of months, & of features unrelated to ME/CFS such as uveitis occurring afterwards as well. Perhaps sometime we could look at what evidence is out there.The Dubbo study found a very similar impact in terms of post-infectious symptoms from EBV, Ross River Fever and Q fever infections. There is quite a bit of evidence that Q fever fatigue syndrome is the same thing. as ME/CFS. Because Q fever is caused by a bacteria, I think it is valid to say that ME/CFS can be caused by some viral infections and some bacterial infections.
I think there is decent evidence to suggest that infections beyond EBV, Ross River Fever and Q fever seem to trigger ME/CFS too. As you say Nightsong, COVID-19 also seems to cause ME/CFS, as did SARS CoV-1 and MERS. Perhaps there is not sufficient evidence to say for certain that, for example, Ebola causes ME/CFS, but it seems likely that it does.